News & Analysis on Clinical Trial Services & Contract Research And Development
In the latest episode of illegal drug trading, a hoard of unlicensed medicines was seized by the UK Medicines and Healthcare products Regulatory Agency (MHRA) last week, taken from a London lock-up containing a stash of various male impotence drugs.
Japan's Chugai Pharmaceuticals is voluntarily recalling almost 2000 bottles of Vesanoid capsules (tretinoin) after the drug was found to contain unapproved bovine-derived material from Canada.
German pharma firm Stada has acquired Russian pharmaceuticals group Makiz in a deal worth up to €135m, giving the company a sturdy foothold in the growing Russian market and enhanced in-house production capacity.
Asuragen has launched a newly expanded miRNA expression profiling service that can search over 13,000 human candidate miRNAs.
Pfizer has initiated a Phase I study for its gastro oesophageal reflux disease (GORD or GERD using the US spelling) therapy that it licensed from Kosan Biosciences, in a deal worth up to $250m (€181m).
Kuehne + Nagel (K + N) has inked a new pact with UK-based drug maker AstraZeneca to provide the global cold chain air and sea freight for some of its products.
PharmaNet has reported second quarter results that place it back in the red after it had only just clawed its way back into the black in the first quarter, following a string of quarterly losses.